Michael Polansky is an American technology executive and nonprofit leader known for his long tenure as executive director of the Parker Institute for Cancer Immunotherapy and his role as a senior advisor to Mark Zuckerberg and Priscilla Chan. This profile explains his verified professional background, leadership responsibilities, and the scope of his work at the intersection of science, philanthropy, and technology policy. It focuses on roles, affiliations, and publicly documented milestones rather than speculative commentary.
Professional Background and Career Path
Michael Polansky began his career in technology and public service roles that led him to prominent positions in philanthropy and nonprofit leadership. His work spans technology policy, scientific research infrastructure, and institutional governance. Over more than a decade at the Parker Institute, he helped scale a nonprofit dedicated to accelerating cancer immunotherapy research through coordinated academic–industry collaboration. His advisory work for Meta leaders has focused on long-term strategy, governance, and philanthropic coordination.
Role at the Parker Institute for Cancer Immunotherapy
Leadership and Institutional Impact
As executive director of the Parker Institute for Cancer Immunotherapy, Polansky was responsible for operations, governance, and execution of a multi-institutional research network. The Parker Institute, founded with a gift from Sean Parker, brings together leading cancer centers to run coordinated clinical trials and share data across institutions. His responsibilities included fundraising, partnership management, and oversight of scientific protocols, ensuring rigorous standards while enabling rapid innovation.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Position | Executive Director | Organization website and press releases |
| Organization | Parker Institute for Cancer Immunotherapy | IRS filings and institutional records |
| Primary Mission | Accelerate cancer immunotherapy through collaborative research | Annual reports and program descriptions |
| Key Function | Network coordination, operations oversight, fundraising | Leadership profiles and board documents |
Advisory Role with Meta and the Chan Zuckerberg Initiative
Strategic and Policy Advisory
Polansky has served as a senior advisor to Mark Zuckerberg and Priscilla Chan, contributing to strategic planning, governance, and philanthropic initiatives. His work has supported efforts to align technology development with scientific research priorities, focusing on long-term impact in health and science. He has helped coordinate internal reviews and external partnerships, ensuring that advisory recommendations are actionable and measurable.
Public Statements and Testimony
Official Hearings and Policy Discussions
Michael Polansky has participated in congressional hearings and policy roundtables on technology, competition, and scientific research. In these settings, he has discussed governance structures for large-scale research initiatives and the role of philanthropic capital in supporting high-risk, high-reward science. His testimony emphasizes institutional coordination, transparency, and measurable outcomes.
- Participated in congressional hearing on competition and platforms
- Spoken at scientific policy events about research infrastructure
- Contributed to discussions on data sharing and privacy safeguards
Key Factual Summary
The following table consolidates verified attributes, timelines, and roles associated with Michael Polansky’s public professional life. These details are drawn from organizational records, legal filings, and statements provided in official settings.
| Metric | Estimate or Range | Context |
|---|---|---|
| Role at Parker Institute | Executive Director (until 2024) | Organization records and announcements |
| Advisory capacity | Senior advisor to Meta leadership | Public disclosures and company filings |
| Industry focus | Technology policy, cancer immunotherapy | Hearings, interviews, published profiles |
| Policy engagements | Congressional testimony, roundtables since 2019 | Hearing transcripts and event records |
Distinctions and Common Clarifications
Separating Verified Facts from Speculation
Public discussion of Michael Polansky sometimes conflates his advisory work with formal corporate roles or overstates the scope of his influence. Verified information indicates he has held leadership positions in nonprofit research infrastructure and provided strategic advisory support to technology leaders. He is not recorded as a corporate officer of Meta Platforms Inc. in publicly filed documents. This profile clarifies roles and affiliations to reduce confusion.
Privacy and Public Profile Considerations
Because of his work with high-profile technology and philanthropic leaders, Polansky’s public profile intersects with debates on privacy, antitrust, and scientific governance. His positions tend to focus on institutional mechanisms rather than personal advocacy. In ongoing discussions about platform regulation and research funding, stakeholders reference his documented roles when assessing coordination between tech platforms and scientific communities.
Comparisons with Similar Profiles
When compared with other nonprofit executives and tech advisors, Polansky’s profile is distinct for its combination of scientific research oversight and technology policy engagement. Unlike many nonprofit leaders who focus narrowly on fundraising or program management, his work emphasizes cross-sector coordination among academia, industry, and philanthropy. This table highlights key contrasts with comparable roles.
| Role | Primary Focus | Notable Context |
|---|---|---|
| Executive Director, Parker Institute | Coordinated cancer immunotherapy research | Multi-institutional trial network |
| Senior Advisor, Meta | Strategic and policy coordination | Supports long-term governance and philanthropic alignment |
| Policy Testimony | Technology competition and research infrastructure | Congressional and regulatory settings |
Status and Change Over Time
Michael Polansky’s roles have evolved alongside shifts in technology regulation and philanthropic strategy. His leadership at the Parker Institute coincided with high-profile collaborative trials and expanded data-sharing agreements. Over time, his advisory work has reflected increased scrutiny of tech platforms, emphasizing transparency and measurement. This timeline section summarizes verified changes in role and responsibility.
Timeline of Documented Roles
| Date or Period | Event | Why It Matters |
|---|---|---|
| 2016–2024 | Executive Director, Parker Institute for Cancer Immunotherapy | Led network of cancer centers and major collaborative trials |
| 2018 onward | Senior advisor to Meta leadership | Guided strategic alignment between tech and research priorities |
| 2019 onward | Congressional testimony and policy roundtables |
Tags
Michael Polansky, Parker Institute, Meta advisor, technology policy, cancer immunotherapy
FAQ
Reader questions
Clarifying Role and Influence
What is Michael Polansky’s primary professional role? He has served as executive director of the Parker Institute for Cancer Immunotherapy and as a senior advisor on strategy and policy to Meta leadership. Does he hold a corporate position at Meta? Public records show advisory roles, not corporate officer positions at Meta Platforms Inc. What sectors does his work connect? His work connects technology policy, scientific research, and philanthropic infrastructure. Has he provided public testimony? Yes, he has testified in congressional hearings and participated in policy roundtables on competition and research governance. What organizations does he work with? He has led the Parker Institute and advised Meta teams focused on long-term strategy and governance. Are there controversies around his role? Public discussion often addresses broader debates on tech influence and research funding; his documented roles focus on institutional coordination and scientific oversight.